Azaindolylidene derivatives as kinase inhibitors, process...

Details Azaindolylidene derivatives as kinase inhibitors, process... Azaindolylidene derivatives as kinase inhibitors, process...

2008-05-13

2008-05-13

Seaman, D. Margaret (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C548S322500

Reexamination Certificate

active

07371862

ABSTRACT:
The present invention is directed to compounds of the formulaor pharmaceutically acceptable salts, prodrug, solvate or optical isomer thereof, pharmaceutical compositions containing same and use thereof for treating diseases linked to disregulated cell proliferation or to disregulated protein kinase.

REFERENCES:
patent: 2002/0022624 (2002-02-01), Dinnell et al.
patent: 2 298 198 (1996-08-01), None
patent: 2 298 199 (1996-08-01), None
patent: WO 94/14808 (1994-07-01), None
patent: WO 96/00226 (1996-01-01), None
patent: WO 97/49703 (1997-12-01), None
patent: WO 01/09121 (2001-02-01), None
patent: WO 01/98299 (2001-12-01), None
patent: WO 02/16348 (2002-02-01), None
patent: WO 03/000688 (2003-01-01), None
patent: WO 2006/040049 (2006-04-01), None
Cohen P., “The Development and Therapeutic Potential of Protein Kinase Inhibitors”,Current Opinion in Chemical Biology, 3:459-465 (1999).
Hosoi T. et al., “Evidence for cdk5 as a Major Activity Phosphorylating Tau Protein in Porcine Brain Extract”,J. Biochem., 117(4):741-749 (1995).
Patani G.A. et al., “Bioisosterism: A Rational Approach in Drug Design”,Chem. Rev., 96:3147-3176 (1996).
Fleisher D. et al., “Improved Oral Drug Delivery: Solubility Limitations Overcome by the Use of Prodrugs”,Advanced Drug Delivery Reviews, 19:115-130 (1996).
Robinson R.P. et al., “Discovery of the Hemifumarate and (α-L-Alanyloxy)Methyl Ether as Prodrugs of an Antirheumatic Oxindole: Prodrugs for the Enolic OH Group”,J. Med. Chem., 39:10-18 (1996).
Verbiscar A.J., “Sythesis of 1-p-Chlorobenzyl-7-Azaindole-3-α-Piperidylmethanol as a Potential Antimalarial Agent”,Journal of Medicinal Chemistry, 15(2):149-152 (1972).
Gálvez C. et al., “Reactivity of 1H-Pyrrolo[2,3-b]Pyridine. I. Synthesis of 3-Acetyl-7-Azaindole and Related Compounds”,J. Heterocyclic Chem., 19:665-667 (1982).
Williams D.L. et al., “The Glyoxalines. V. The Bromination of 2-Phenyl-4-Benzal-5-Glyoxalidone”,J. Am. Chem. Soc., 68:647-649 (1946).
Khodair A.I. et al., “Synthesis, Conformational Analysis and Antitumor Testing of 5-(Z)-Arylidene-4-Imidazolidinone Derivatives”,Phosphorus, Sulfur and Silicon, 140:159-181 (1998).

Affiliated with

Also associated with

Rating

Azaindolylidene derivatives as kinase inhibitors, process... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Azaindolylidene derivatives as kinase inhibitors, process..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azaindolylidene derivatives as kinase inhibitors, process... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2813057